Faron Pharmaceuticals Oy Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.4%.

Top 18 shareholders own 49.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.6%	Timo Syrjälä	13,410,336	UK£19.4m	1.42%	no data
4.73%	A&B (HK) Company Limited	3,408,409	UK£4.9m	0%	no data
4.6%	Markku Jalkanen	3,313,434	UK£4.8m	0.66%	no data
4.49%	Tom-Erik Lind	3,231,797	UK£4.7m	-11.9%	no data
3.94%	Varma Mutual Pension Insurance Company, Asset Management Arm	2,837,581	UK£4.1m	50%	0.03%
3.73%	Marko Salmi	2,685,079	UK£3.9m	0.93%	no data
3.47%	Fourth Swedish National Pension Fund (AP4)	2,501,769	UK£3.6m	-2.89%	0.02%
2.89%	The European Investment Council Fund, Eic	2,080,437	UK£3.0m	0%	no data
0.93%	Sp-Rahastoyhtiö Oy	671,840	UK£974.2k	0%	0.05%
0.85%	Danske Capital Denmark	611,664	UK£886.9k	22.3%	no data
0.83%	OP Varainhoito Oy	598,793	UK£868.2k	0%	0.01%
0.46%	Fondita Rahastoyhtio AB	330,491	UK£479.2k	0%	0.09%
0.099%	Frank Armstrong	71,062	UK£103.0k	0%	no data
0.058%	Bg Fund Management Luxembourg S.A.	41,736	UK£60.5k	0%	no data
0.016%	Tuomo Patsi	11,765	UK£17.1k	0%	no data
0.014%	John Poulos	10,000	UK£14.5k	0%	no data
0.0028%	Erik Ostrowski	2,009	UK£2.9k	0%	no data
0.00007%	Tomi Yli-Kyyny	50	UK£73.1	0%	no data